Bookmark and Share
10-hydroxycamptothecin (CID 97226) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(134)
 
 
Inactive(114)
 
 
Inconclusive(21)
 
 
Unspecified(51)
 
 
Top Targets:
PLDc mTdp1 2(6)
 
 
 
NR LBD ROR li..(4)
 
 
HELICc(4)
 
 
PLN02808(4)
 
 
Bromo ALL-1(4)
 
 
 
BioAssay Types:
Confirmatory(186)
 
 
 
 
Literature(102)
 
 
 
 
Screening(13)
 
 
BioActivity Types:
Potency(106)
 
 
 
 
IC50(44)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 275    Data Row: 320   Total Pages: 7   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103170545]
IC50 0.004Cytotoxicity against human A2780 cells overexpressing alpha5beta3 integrin assessed as cell survival after 72 hrs by SRB assay [AID690722, Type: Literature]
View
2
[SID103170545]
IC50 0.0054Cytotoxicity against human HepG2 cells assessed as inhibition of [3H]thymidine after 48 hrs [AID326456, Type: Literature]
View
3
[SID103170545]
IC50 0.0069Cytotoxicity against human H298 cells assessed as inhibition of [3H]thymidine after 48 hrs [AID326459, Type: Literature]
View
4
[SID103170545]
IC50 0.0088Cytotoxicity against human HT29 cells assessed as inhibition of [3H]thymidine after 48 hrs [AID326458, Type: Literature]
View
5
[SID103170545]
IC50 0.0091Cytotoxicity against human Colo 205 cells assessed as inhibition of [3H]thymidine after 48 hrs [AID326457, Type: Literature]
View
6
[SID103170545]
IC50 0.012Inhibitory activity against P388 Leukemia cells [AID150662, Type: Literature]
View
7
[SID103170545]
IC50 0.018Inhibitory activity in mice bearing L1210 leukemia [AID100463, Type: Literature]
View
8
[SID50107786]
Potency 0.0184qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
9
[SID26750003]
Potency 0.0206qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
10
[SID103170545]
IC50 0.03Cytotoxicity against human Jurkat cells after 48 hrs by MTT assay [AID481528, Type: Literature]
View
11
[SID103170545]
IC50 0.0312Cytotoxicity against human HCT116 after 72 hrs by SRB assay [AID666763, Type: Literature]
View
12
[SID103170545]
IC50 0.0336Cytotoxicity against human A549 after 72 hrs by SRB assay [AID666764, Type: Literature]
View
13
[SID103170545]
GI50 0.036Mean GI50 against variety of human tumor cell lines [AID222948, Type: Literature]
View
14
[SID103170545]
IC50 0.04Cytotoxicity against human HL60 cells after 48 hrs by MTT assay [AID481527, Type: Literature]
View
15
[SID50107786]
Potency 0.0517qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
16
[SID26750003]
Potency 0.058qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
17
[SID103170545]
IC50 0.078Cytotoxicity against human PC3 cells expressing alpha5beta3 integrin assessed as cell survival after 72 hrs by SRB assay [AID690587, Type: Literature]
View
18
[SID103170545]
IC50 0.11Cytotoxicity against human U937 cells after 48 hrs by MTT assay [AID481529, Type: Literature]
View
19
[SID103170545]
IC50 0.11Antitumor activity against human A549/ATCC cells by SRB method [AID426062, Type: Literature]
View
20
[SID103170545]
IC50 0.11Inhibition of Topoisomerase I by cleavage complex formation in human HL-60 cells [AID210946, Type: Literature]
View
21
[SID26750003]
Potency 0.1122qHTS for Inhibitors of binding or entry into cells for Lassa Virus [AID720533, Type: confirmatory]
View
22
[SID103170545]
IC50 0.14Growth inhibition of human SMMC7721 cells after 48 hrs by MTT assay [AID468115, Type: Literature]
View
23
[SID103170545]
IC50 0.148Inhibitory concentration against human HCT116 colon cancer cell line [AID247623, Type: Literature]
View
24
[SID103170545]
IC50 0.16Cytotoxicity against human K562 cells after 72 hrs by MTT assay [AID477404, Type: Literature]
View
25
[SID103170545]
IC50 0.2Cytotoxicity against human Bel7402 cells after 48 hrs by MTT assay [AID431814, Type: Literature]
View
26
[SID103170545]
IC50 0.21Antitumor activity against human HT-29 cells by SRB method [AID426063, Type: Literature]
View
27
[SID103170545]
IC50 0.23Antitumor against human GLC82 cells assessed as cell survival after 48 hrs by MTT assay [AID611122, Type: Literature]
View
28
[SID103170545]
IC50 0.28Cytotoxicity against human Bel-7402 cells after 72 hrs by sulforhodamine B assay [AID379166, Type: Literature]
View
29
[SID103170545]
IC50 0.36Cytotoxicity against human Bel7402 cells after 72 hrs by SRB assay [AID477406, Type: Literature]
View
30
[SID103170545]
IC50 0.37Cytotoxicity against human CNE2 cells after 48 hrs by MTT assay [AID436375, Type: Literature]
View
31
[SID103170545]
IC50 0.4Cytotoxicity against human Bel7402 cells after 72 hrs by SRB assay [AID421696, Type: Literature]
View
32
[SID103170545]
IC50 0.41Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay [AID379165, Type: Literature]
View
33
[SID103170545]
IC50 0.496Antitumor activity against mouse C26 cells by WST-1 assay [AID591019, Type: Literature]
View
34
[SID103170545]
IC50 0.6Cytotoxicity against human KB cells after 48 hrs by MTT assay [AID431812, Type: Literature]
View
35
[SID103170545]
IC50 0.7Cytotoxicity against human A2780 cells after 48 hrs by MTT assay [AID431813, Type: Literature]
View
36
[SID103170545]
IC50 0.829Antitumor activity against human KB cells by WST-1 assay [AID591017, Type: Literature]
View
37
[SID103170545]
IC50 0.981Antitumor activity against human HepG2 cells by WST-1 assay [AID591018, Type: Literature]
View
38
[SID103170545]
CC50 1Cytotoxicity against DNA topoisomerase I purified from calf thymus [AID56562, Type: Literature]
View
39
[SID103170545]
IC50 1.04Antitumor against human CNE2 cells assessed as cell survival after 48 hrs by MTT assay [AID611121, Type: Literature]
View
40
[SID103170545]
IC50 1.09Cytotoxicity against human GLC82 cells after 48 hrs by MTT assay [AID436376, Type: Literature]
View
41
[SID103170545]
IC50 2.47Inhibitory concentration against human Bel-7402 liver cancer cell line [AID247637, Type: Literature]
View
42
[SID103170545]
IC50 3.7Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay [AID481526, Type: Literature]
View
43
[SID103170545]
IC50 4.1Cytotoxicity against human K562 cells after 72 hrs by MTT assay [AID421695, Type: Literature]
View
44
[SID103170545]
IC50 6.49Cytotoxicity against human Hep G2 after 48 hrs by MTT assay [AID378061, Type: Literature]
View
45
[SID26750003]
Potency 10qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium [AID1457, Type: confirmatory]Inositol monophosphatase 1 [gi:44888968]
View
46
[SID26750003]
Potency 12.5893Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus [AID910, Type: confirmatory]hemoglobin subunit beta [Homo sapiens] [gi:4504349]
View
47
[SID26750003]
Potency 12.5893qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 [AID884, Type: confirmatory]cytochrome P450 3A4 isoform 1 [Homo sapiens] [gi:13435386]
View
48
[SID103170545]
IC50 19.12Cytotoxicity against human MCF7 after 48 hrs by MTT assay [AID378062, Type: Literature]
View
49
[SID103170545]
IC50 21.3Cytotoxicity against human 95-D cells [AID711440, Type: Literature]
View
50
[SID103170545]
IC50 29.5Cytotoxicity against human HeLa cells [AID711441, Type: Literature]
View